HC Wainwright & Co. Maintains Buy on Spectrum Pharmaceuticals, Lowers Price Target to $6

HC Wainwright & Co. analyst Edward White maintains Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Buy and lowers the price target from $9 to $6.

HC Wainwright & Co. analyst Edward White maintains Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Buy and lowers the price target from $9 to $6.

Total
0
Shares
Related Posts